Financial PerformanceMariMed Inc. reported Q4 results that were below expectations with sales and adjusted EBITDA falling well below both analyst expectations and management’s revised guidance.
Future GuidanceMariMed Inc. projected a conservative outlook for 2024, with revenue and adjusted EBITDA growth forecasts not meeting the consensus estimates, indicating potential challenges ahead.
Operating CostsIncreased operating costs, stemming from construction delays, higher-than-expected staffing costs, and other start-up expenses, significantly impacted MariMed Inc.'s recent financial performance.